mifepristone has been researched along with Hemorrhage, Uterine in 93 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (9.68) | 18.7374 |
1990's | 26 (27.96) | 18.2507 |
2000's | 33 (35.48) | 29.6817 |
2010's | 17 (18.28) | 24.3611 |
2020's | 8 (8.60) | 2.80 |
Authors | Studies |
---|---|
Enzelsberger, SH; Hermann, P; Oppelt, P; Shebl, O; Trautner, PS; Wagner, H; Wetzlmair, D | 1 |
Braat, DDM; Coppus, SFPJ; Hamel, CC; Snijders, MPLM; Vandenbussche, FPHA; Vart, P | 1 |
Guowen, LI; Huifeng, W; Jie, LI; Lijun, YU; Tiantian, Z; Yuan, G; Zhifeng, C | 1 |
Huang, Q; Li, LL; Peng, DY; Qi, JJ; Yao, M | 1 |
Chen, MJ; Creinin, MD; Dalton, L; Hou, MY; Steward, R | 1 |
Atrio, JM; Creinin, MD; Koelper, N; McAllister, A; Sammel, MD; Schreiber, CA; Sonalkar, S | 1 |
Mihalceanu, E; Onofriescu, M; Pintilie, R; Pristavu, A; Socolov, D; Vinturache, A | 1 |
Aronowitz, SV | 1 |
Heikinheimo, O; Korjamo, R; Mentula, M | 1 |
Bouchard, P; Chabbert-Buffet, N; Daraï, E; Kolanska, K | 1 |
Aabø, RS; Iversen, OE; Janbu, T; Løkeland, M; Pay, ASD; Økland, I | 1 |
Kovač, V; Reljič, M; Serdinšek, T | 1 |
Chen, J; Guo, Q; Huang, B; Qiu, L; Ren, Z; Wan, R; Wang, M; Wang, X; Wang, Y; Ying, J; Yu, H; Yu, J | 1 |
Guo, Y; Jiang, G; Li, X; Li, Y; Wang, B; Wang, L; Yao, C; Zhang, M; Zhao, X; Zhou, X | 1 |
Bjørge, L; Engeland, A; Iversen, OE; Løkeland, M; Økland, I | 1 |
Cui, J; Cui, W; Shao, X; Wen, P | 1 |
Friedlander, E; Kaneshiro, B | 1 |
Frank, K; Gerychová, R; Huser, M; Janků, P; Ventruba, P | 1 |
Bouchard, P; Chabbert-Buffet, N; Kairis, AP; Ouzounian, S | 1 |
Huang, L; Li, L; Zhou, Z | 1 |
Findlay, JK; Fraser, IS; Hickey, M; O'Connor, V; Palmer, D; Salamonsen, LA; Weisberg, E | 1 |
Engman, M; Gemzell-Danielsson, K; Granberg, S; Lalitkumar, PG; Meng, CX; Williams, AR | 1 |
Bonfiglio, T; Eisinger, SH; Fiscella, J; Fiscella, K; Meldrum, S | 1 |
Chi, X; Guo, Y; Jiang, G; Li, X; Liu, R; Ma, R; Wang, B; Wang, L; Yao, C; Zhang, W; Zhou, X | 1 |
Achilles, SL; Creinin, MD; Hayes, JL; Reeves, MF | 1 |
Chen, FH; Li, CW; Li, JP; Li, X; Lu, WG; Yuan, FL; Zhao, YQ | 1 |
Burger, HG; Croxatto, HB; Findlay, JK; Fraser, IS; Weisberg, E | 1 |
Chen, AM; Cheng, YM; Gao, ES; Liang, H; Luo, L; Yuan, W | 1 |
Guo, Y; Jiang, G; Li, X; Li, Y; Wang, B; Wang, L; Yao, C; Zhao, X; Zhou, X | 1 |
Chen, DJ; Du, PL; Li, CL; Liu, MX; Liu, Q; Sheng, XJ; Wei, M; Weng, HN | 1 |
Ho, PC; Lee, SW; Tang, OS | 1 |
Fielding, SL; Schaff, EA; Westhoff, C | 1 |
Baird, DT; Critchley, HO; Hapangama, DK; Henderson, TA | 1 |
Ma, DM; Sun, HL; Yang, ML | 1 |
Dai, M; Liu, Q; Peng, D; Zi, X | 1 |
Hausknecht, R | 1 |
Felix, JC; Jain, JK; Kuo, J; Lu, JJ; Nicosia, AF; Nucatola, DL | 1 |
Croxatto, HB; d'Arcangues, C; Fuentealba, B; Massai, MR; Pavez, M | 1 |
Hu, CF; Long, X; Wu, KM; Zeng, J; Zeng, N; Zhang, LM | 1 |
Hwang, AC; Stewart, FH; Taylor, D | 1 |
Chien, P; Guest, J; Kosseim, ML; Thomson, M | 1 |
Arvidsson, C; Gemzell-Danielsson, K; Hellborg, M | 1 |
Borgatta, L; Chen, AY; Mottl-Santiago, J; Vragovic, O; Wasserman, S | 1 |
Dunn, S; Guilbert, E; Jacot, F; Shannon, C; Sheldon, WR; Wiebe, E; Winikoff, B | 1 |
Baird, D; von Hertzen, H | 1 |
Sitruk-Ware, R | 1 |
Cheng, L | 1 |
Fiala, C; Gemzel-Danielsson, K | 1 |
Dempsey-Fanning, A; Teal, SB; Westhoff, C | 1 |
Felix, JC; Jain, JK; Li, A; Minoo, P; Xiong, DW; Yang, W | 1 |
Cheng, LN; Du, MK; Lu, YL; Sang, GW; Shao, QX; Weng, LJ; Wu, XZ | 1 |
Cen, HX; Jin, YC; Xu, MF | 1 |
Peplow, PV | 1 |
Silvestre, L; Ulmann, A | 1 |
Chan, YF; Ho, PC; Ma, HK | 1 |
Baton-Saint-Mleux, C; Bourget, P; Fernandez, H; Frydman, R; Lelaidier, C | 1 |
Choolani, M; Prasad, RN; Ratnam, SS; Roy, A | 1 |
Aubény, E; Baulieu, EE; Peyron, R; Renault, M; Silvestre, L; Targosz, V; Turpin, CL; Ulmann, A | 1 |
Ho, PC; Lao, T; Ngai, SW; Yeung, KC | 1 |
Eisinger, SH; Franks, P; Schaff, EA; Stadalius, LS | 1 |
Pan, J; Sun, L | 1 |
Bardin, CW; Benton, L; Robbins, A; Spitz, IM | 1 |
El-Refaey, H; Templeton, A | 1 |
Ashok, PW; Flett, GM; Templeton, A | 1 |
Baird, DT; Brown, AH; Martin, CW | 1 |
Coyaji, K; Ellertson, C; Harper, C; Winikoff, B | 1 |
Cheng, L; Gao, PP; Ho, PC; Lee, SW; Tang, OS | 1 |
Dai, DY; Wu, DX; Zhang, TT | 1 |
Brooks, L; Grinsted, J; Grinsted, L; Jacobsen, JD; Nielsen, SP; Sandstrøm, O; Schantz, A | 1 |
Davis, A; De Nonno, L; Westhoff, C | 1 |
Chen, J; Cheng, L; Glasier, A; Ren, F; Wang, A; Zhu, H | 1 |
De Nonno, LJ; Fielding, S; Schaff, E; Westhoff, C | 1 |
Li, D; Qiu, X; Zhou, X | 1 |
Cheng, L; Tong, C; Xiao, Z | 1 |
Ashok, PW; Narvekar, N; Smith, NC; Templeton, A; Wagaarachchi, PT | 1 |
Cheng, L; Ho, PC; Lee, SW; Tang, OS; Xu, J | 1 |
Wang, Z | 1 |
Critchley, HO; Davie, JE; Glasier, AF; Kelly, RW; Wang, H | 1 |
Weimin, W; Wenqing, L | 1 |
Berer, M | 1 |
Aubeny, E | 1 |
Elie, R; Lanza, E; Lefebvre, Y; Poulin, O; Proulx, L | 1 |
Baulieu, EE; Dubois, C; Renault, M; Rezvani, Y; Silvestre, L; Ulmann, A | 1 |
Philibert, D; Teutsch, G; Ulmann, A | 1 |
Schaison, G | 1 |
Grimes, DA; Lacarra, M; Mishell, DR; Shoupe, D | 1 |
Baird, DT; Rodger, MW | 1 |
Carol, W; Klinger, G | 1 |
Croxatto, HB; Croxatto, HD; Salvatierra, AM; Spitz, IM | 1 |
Kerrigan, P | 1 |
Chaneac, M; Maria, B; Stampf, F; Ulmann, A | 1 |
Brenner, PF; Mishell, DR; Shoupe, D; Spitz, IM | 1 |
Baulieu, EE; Couzinet, B; Le Strat, N; Schaison, G; Ulmann, A | 1 |
8 review(s) available for mifepristone and Hemorrhage, Uterine
Article | Year |
---|---|
Selective progesterone receptor modulators: current applications and perspectives.
Topics: Abortion, Induced; Endometriosis; Female; Humans; Leiomyoma; Mifepristone; Norpregnadienes; Pregnancy; Progesterone; Receptors, Progesterone; Uterine Hemorrhage; Uterine Neoplasms | 2018 |
Therapeutic Options for Unscheduled Bleeding Associated with Long-Acting Reversible Contraception.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraception; Doxycycline; Female; Hormone Antagonists; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Matrix Metalloproteinase Inhibitors; Mifepristone; Practice Guidelines as Topic; Time Factors; Tranexamic Acid; Uterine Hemorrhage | 2015 |
Contraceptive applications of progesterone receptor modulators.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Female; Humans; Mifepristone; Ovulation; Receptors, Progesterone; Uterine Hemorrhage | 2008 |
Care for women choosing medication abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Decision Making; Female; Humans; Mifepristone; Patient Education as Topic; Pregnancy; Uterine Hemorrhage | 2004 |
Mifepristone and misoprostol sequential regimen side effects, complications and safety.
Topics: Abortifacient Agents; Abortion, Induced; Animals; Clinical Trials as Topic; Female; Humans; Mifepristone; Misoprostol; Pelvic Infection; Pregnancy; Uterine Hemorrhage | 2006 |
Medical abortion in early pregnancy: experience in China.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; China; Chorionic Gonadotropin; Dinoprost; Female; Gestational Age; History, 20th Century; Humans; Mifepristone; Pregnancy; Uterine Hemorrhage | 2006 |
Review of medical abortion using mifepristone in combination with a prostaglandin analogue.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Sublingual; Analgesia, Obstetrical; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Prostaglandins; Time Factors; Uterine Contraction; Uterine Hemorrhage; World Health Organization | 2006 |
Effect of early pregnancy on a previous lower segment cesarean section scar.
Topics: Adult; Cesarean Section; Chorionic Gonadotropin, beta Subunit, Human; Cicatrix; Female; Humans; Hysterectomy; Methotrexate; Mifepristone; Postoperative Complications; Pregnancy; Trichosanthin; Ultrasonography; Uterine Hemorrhage; Uterine Rupture | 2002 |
47 trial(s) available for mifepristone and Hemorrhage, Uterine
Article | Year |
---|---|
Predicting the likelihood of successful medical treatment of early pregnancy loss: development and internal validation of a clinical prediction model.
Topics: Abortion, Spontaneous; Colic; Female; Humans; Male; Mifepristone; Models, Statistical; Pregnancy; Probability; Prognosis; Uterine Hemorrhage | 2022 |
Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adult; California; Chorionic Gonadotropin; Double-Blind Method; Female; Gestational Age; Humans; Mifepristone; Pregnancy; Progesterone; Uterine Hemorrhage; Vacuum Curettage; Young Adult | 2020 |
Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Treatment Outcome; Uterine Hemorrhage | 2020 |
Fast-track vs. delayed insertion of the levonorgestrel-releasing intrauterine system after early medical abortion - a randomized trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Feasibility Studies; Female; Finland; Follow-Up Studies; Humans; Intention to Treat Analysis; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Mifepristone; Misoprostol; Patient Dropouts; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Time Factors; Uterine Hemorrhage; Young Adult | 2017 |
Shenghua Decoction reduces uterine bleeding and regulates T-cell paradigm in human deciduas of RU486 medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cytokines; Decidua; Drugs, Chinese Herbal; Female; Forkhead Transcription Factors; GATA3 Transcription Factor; Humans; Mifepristone; Nuclear Receptor Subfamily 1, Group F, Member 3; Pregnancy; T-Box Domain Proteins; T-Lymphocyte Subsets; T-Lymphocytes; Uterine Hemorrhage; Young Adult | 2013 |
Application prospect and clinical effect analysis of Fu Chan Xue Jing during bleeding after abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drugs, Chinese Herbal; Female; Humans; Menstruation; Mifepristone; Postoperative Hemorrhage; Pregnancy; Uterine Hemorrhage; Young Adult | 2015 |
A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Doxycycline; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Mifepristone; Uterine Hemorrhage | 2009 |
Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial.
Topics: Adult; Double-Blind Method; Female; Hemoglobins; Humans; Leiomyoma; Middle Aged; Mifepristone; Regional Blood Flow; Uterine Hemorrhage; Uterine Neoplasms; Uterus | 2009 |
Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata.
Topics: Administration, Oral; Adult; Dose-Response Relationship, Drug; Female; Health Status; Hormone Antagonists; Humans; Leiomyoma; Middle Aged; Mifepristone; Pain; Quality of Life; Uterine Hemorrhage; Uterine Neoplasms | 2009 |
Up-regulation of Fas/FasL activation contribute to the apoptosis enhancement of RU486 by Gong-Qing Decoction, a traditional Chinese prescription.
Topics: Abortion, Induced; Adult; Apoptosis; Caspase 3; Caspase 8; Drug Therapy, Combination; Drugs, Chinese Herbal; Fas Ligand Protein; Female; Humans; Mifepristone; Phytotherapy; Pregnancy; Up-Regulation; Uterine Hemorrhage; Uterus; Vacuum Curettage; Young Adult | 2011 |
A randomized study of the effect of mifepristone alone or in conjunction with ethinyl estradiol on ovarian function in women using the etonogestrel-releasing subdermal implant, Implanon®.
Topics: Adolescent; Adult; Cervix Mucus; Contraceptive Agents, Female; Desogestrel; Double-Blind Method; Drug Implants; Drug Interactions; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Humans; Luteinization; Menstrual Cycle; Middle Aged; Mifepristone; Ovary; Ovulation Inhibition; Ultrasonography; Uterine Hemorrhage; Viscosity; Young Adult | 2011 |
[The lowest dosages of mifepristone and misoprostol to terminate ultra-early pregnancy].
Topics: Abdominal Pain; Abortifacient Agents; Abortion, Induced; Administration, Oral; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Nausea; Patient Satisfaction; Pregnancy; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2012 |
A prospective randomized study on the measured blood loss in medical termination of early pregnancy by three different misoprostol regimens after pretreatment with mifepristone.
Topics: Abortifacient Agents, Steroidal; Adult; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Failure; Uterine Hemorrhage | 2002 |
Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Treatment Outcome; Uterine Hemorrhage | 2002 |
[Clinical observation on effect of xuejie jiawei decoction on vaginal hemorrhagic amount and duration in patients after drug-abortion].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drugs, Chinese Herbal; Female; Humans; Mifepristone; Phytotherapy; Pregnancy; Uterine Hemorrhage | 2001 |
Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Endometrium; Estrogen Receptor alpha; Estrogens; Female; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Mifepristone; Ovulation; Progesterone; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Time Factors; Uterine Hemorrhage | 2003 |
Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levonorgestrel; Mifepristone; Pregnancy; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 2004 |
Randomised controlled trial comparing efficacy of same day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36- to 48-hour protocol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Clinical Protocols; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Treatment Outcome; Uterine Hemorrhage | 2005 |
Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Administration, Topical; Analgesics; Female; Humans; Mifepristone; Misoprostol; Nausea; Pain; Patient Acceptance of Health Care; Patient Satisfaction; Pregnancy; Uterine Hemorrhage; Vagina; Vomiting | 2005 |
Bleeding after medication-induced termination of pregnancy with two dosing schedules of mifepristone and misoprostol.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Time Factors; Uterine Hemorrhage | 2006 |
Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Treatment Outcome; Uterine Hemorrhage | 2006 |
Predictors of acceptability of medication abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Parity; Patient Acceptance of Health Care; Pregnancy; Treatment Failure; Uterine Hemorrhage | 2007 |
Effect of mifepristone on endometrial matrix metalloproteinase expression and leukocyte abundance in new medroxyprogesterone acetate users.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; DNA Primers; Double-Blind Method; Endometrium; Female; Humans; Immunohistochemistry; Leukocytes; Matrix Metalloproteinases; Medroxyprogesterone Acetate; Middle Aged; Mifepristone; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Treatment Outcome; Uterine Hemorrhage | 2007 |
Termination of early pregnancy by two regimens of mifepristone with misoprostol and mifepristone with PG05--a multicentre randomized clinical trial in China.
Topics: Abdominal Pain; Abortion, Induced; Administration, Oral; Adolescent; Adult; China; Diarrhea; Dinoprost; Dose-Response Relationship, Drug; Female; Humans; Mifepristone; Misoprostol; Pessaries; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage | 1994 |
RU486: the French experience.
Topics: Abdominal Pain; Abortion, Induced; Adult; Alprostadil; Contraindications; Dinoprostone; Female; France; Humans; Hypotension; Mifepristone; Misoprostol; Myocardial Infarction; Pilot Projects; Pregnancy; Uterine Hemorrhage | 1994 |
Blood loss in termination of early pregnancy by vacuum aspiration and by combination of mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Adult; Alprostadil; Dose-Response Relationship, Drug; Female; Hemoglobins; Humans; Mifepristone; Pregnancy; Suction; Uterine Hemorrhage | 1993 |
Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial.
Topics: Abortion, Missed; Adult; Double-Blind Method; Female; Humans; Mifepristone; Placebos; Pregnancy; Prospective Studies; Uterine Hemorrhage | 1993 |
Blood loss in termination of early pregnancy with mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Alprostadil; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage | 1995 |
Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol [corrected].
Topics: Abortifacient Agents; Adolescent; Adult; Amenorrhea; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; France; Hemostatic Techniques; Humans; Incidence; Menstruation-Inducing Agents; Mifepristone; Misoprostol; Pregnancy; Pregnancy, Ectopic; Time Factors; Ultrasonography; Uterine Hemorrhage; Uterus | 1995 |
Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: a double blind prospective randomised study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adult; Double-Blind Method; Female; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Tablets; Uterine Hemorrhage; Vacuum Extraction, Obstetrical | 1996 |
Early pregnancy termination with mifepristone and misoprostol in the United States.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Receptors, Progesterone; Treatment Failure; United States; Uterine Hemorrhage | 1998 |
A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Blood Cell Count; Contraceptives, Oral, Combined; Female; Humans; Menstrual Cycle; Methotrexate; Mifepristone; Pessaries; Pregnancy; Prostaglandins; Uterine Hemorrhage | 1998 |
Blood loss with mifepristone--misoprostol abortion: measures from a trial in China, Cuba and India.
Topics: Abortifacient Agents; Abortion, Therapeutic; Adult; Blood Loss, Surgical; Cuba; Feasibility Studies; Female; Humans; India; Logistic Models; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Software; Uterine Hemorrhage | 1998 |
A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Missed; Adult; Contraceptives, Oral; Double-Blind Method; Female; Hemoglobins; Humans; Mifepristone; Misoprostol; Placebos; Pregnancy; Time Factors; Uterine Hemorrhage | 1999 |
[Clinical and experimental studies on qumotang for bleeding after medical abortion in 214 cases].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Animals; Drugs, Chinese Herbal; Female; Humans; Mifepristone; Pregnancy; Rabbits; Uterine Contraction; Uterine Hemorrhage | 1997 |
Interruption of early pregnancy with mifepristone in combination with gemeprost.
Topics: Abdominal Pain; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Time Factors; Treatment Outcome; Uterine Hemorrhage | 1999 |
Bleeding patterns after early abortion with mifepristone and misoprostol or manual vacuum aspiration.
Topics: Abortion, Induced; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Uterine Hemorrhage; Vacuum Curettage; Vacuum Extraction, Obstetrical | 2000 |
Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Double-Blind Method; Drug Implants; Female; Hormone Antagonists; Humans; Levonorgestrel; Mifepristone; Placebos; Progesterone; Time Factors; Uterine Hemorrhage | 2000 |
Timing of pain and bleeding after mifepristone-induced abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Administration Schedule; Dysmenorrhea; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Statistics, Nonparametric; Time Factors; Uterine Hemorrhage | 2000 |
[Low doses of mifepristone for emergency contraception].
Topics: Adolescent; Adult; Contraception; Contraceptives, Postcoital, Synthetic; Female; Follow-Up Studies; Humans; Middle Aged; Mifepristone; Nausea; Uterine Hemorrhage | 1999 |
The effect of contraceptive pills on the measured blood loss in medical termination of pregnancy by mifepristone and misoprostol: a randomized placebo controlled trial.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Contraceptives, Oral; Female; Hemoglobins; Humans; Mifepristone; Misoprostol; Placebos; Pregnancy; Uterine Hemorrhage | 2002 |
[Prevent from bleeding after medical abortion through prolonged application of mifepristone with misoprostol for terminating early pregnancy].
Topics: Abortion, Induced; Female; Humans; Menstruation; Mifepristone; Misoprostol; Time Factors; Uterine Hemorrhage | 2000 |
Administration of an antiprogesterone up-regulates estrogen receptors in the endometrium of women using Norplant: a pilot study.
Topics: Biopsy; Contraceptives, Oral, Synthetic; Drug Interactions; Endometrium; Female; Hormone Antagonists; Humans; Immunohistochemistry; Levonorgestrel; Mifepristone; Pilot Projects; Progesterone; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Single-Blind Method; Statistics, Nonparametric; Up-Regulation; Uterine Hemorrhage | 2002 |
RU486 combined with PG analogs in voluntary termination of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Prostaglandins, Synthetic; Uterine Hemorrhage | 1991 |
Emergency contragestion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Estradiol; Estrenes; Female; Humans; Menstruation-Inducing Agents; Mifepristone; Peptide Fragments; Pregnancy; Progesterone; Uterine Hemorrhage | 1987 |
Early abortion with a single dose of the antiprogestin RU-486.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Clinical Trials as Topic; Estrenes; Female; Humans; Menstrual Cycle; Mifepristone; Peptide Fragments; Pregnancy; Tablets; Time Factors; Uterine Hemorrhage | 1988 |
Pregnancy termination with a high and medium dosage regimen of RU 486.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Evaluation; Estrenes; Female; Humans; Hydrocortisone; Mifepristone; Pregnancy; Receptors, Progesterone; Uterine Hemorrhage; Vomiting | 1986 |
38 other study(ies) available for mifepristone and Hemorrhage, Uterine
Article | Year |
---|---|
Bleeding pattern after medical management of early pregnancy loss with mifepristone-misoprostol and its prognostic value: a prospective observational cohort study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prognosis; Prospective Studies; Uterine Hemorrhage | 2022 |
Efficacy of Qiancao () and Haipiaoxiao (), a traditional Chinese herb pair, on abnormal uterine bleeding in rats with incomplete abortion.
Topics: Abortion, Incomplete; Abortion, Induced; Animals; China; Female; Humans; Mifepristone; Pregnancy; Rats; Uterine Hemorrhage | 2022 |
[Simultaneous determination and pharmacokinetic study of five compounds from total extract of Clinopodium chinense in abnormal uterine bleeding rat plasma by UPLC-MS/MS].
Topics: Administration, Oral; Animals; Apigenin; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drugs, Chinese Herbal; Female; Flavonoids; Hesperidin; Lamiaceae; Mifepristone; Misoprostol; Oleanolic Acid; Plant Extracts; Rats; Saponins; Tandem Mass Spectrometry; Uterine Hemorrhage | 2022 |
Combination of medical and surgical management in successful treatment of caesarean scar pregnancy: a case report series.
Topics: Abortion, Induced; Adult; Cesarean Section; Cicatrix; Combined Modality Therapy; Curettage; Female; Fertility Preservation; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prospective Studies; Treatment Outcome; Ultrasonography, Doppler, Color; Uterine Artery Embolization; Uterine Hemorrhage; Uterus; Young Adult | 2020 |
Taking Call.
Topics: Abortion, Induced; Dysmenorrhea; Female; Humans; Mifepristone; Telemedicine; Uterine Hemorrhage | 2021 |
Medical abortions performed by specialists in private practice.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Norway; Pain; Parity; Patient Safety; Patient Satisfaction; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Private Practice; Self Administration; Surveys and Questionnaires; Uterine Hemorrhage; Young Adult | 2018 |
Medical management of first trimester missed miscarriage: the efficacy and complication rate.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Missed; Adolescent; Adult; Chorionic Gonadotropin, beta Subunit, Human; Curettage; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Uterine Hemorrhage; Young Adult | 2019 |
Serum angiopoietin-2 and β-hCG as predictors of prolonged uterine bleeding after medical abortion in the first trimester.
Topics: Abortion, Induced; Adult; Angiopoietin-2; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Uterine Hemorrhage; Young Adult | 2013 |
Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Therapy, Combination; Female; Gestational Age; Health Services Accessibility; Humans; Mifepristone; Misoprostol; Odds Ratio; Pain; Patient Acceptance of Health Care; Patient Satisfaction; Pregnancy; Prospective Studies; Self Administration; Travel; Uterine Hemorrhage | 2014 |
[Medical termination of pregnancy by mifepristone and misoprostol - evaluation of succes rate, complications and satisfaction of patients].
Topics: Abortifacient Agents; Abortion, Induced; Adult; Cohort Studies; Dilatation and Curettage; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Nausea; Personal Satisfaction; Pregnancy; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome; Uterine Hemorrhage; Vomiting | 2015 |
Abnormal expression of MMP-9 and imbalance of MMP-9/TIMP-1 is associated with prolonged uterine bleeding after a medical abortion with mifepristone and misoprostol.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Cross-Sectional Studies; Female; Humans; Matrix Metalloproteinase 9; Mifepristone; Misoprostol; Pregnancy; Tissue Inhibitor of Metalloproteinase-1; Uterine Hemorrhage | 2009 |
Outcomes of medical abortion through 63 days in women with twin gestations.
Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Humans; Mifepristone; Misoprostol; Pain Measurement; Postoperative Complications; Pregnancy; Pregnancy, Multiple; Randomized Controlled Trials as Topic; Treatment Outcome; Twins; Uterine Hemorrhage | 2011 |
Effects of leonurine hydrochloride on medically induced incomplete abortion in early pregnancy rats.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Animals; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Estradiol; Female; Gallic Acid; In Vitro Techniques; Mifepristone; Misoprostol; Organ Size; Pregnancy; Random Allocation; Rats; Rats, Sprague-Dawley; Uterine Contraction; Uterine Hemorrhage; Uterus | 2011 |
Mifepristone-induced abortion and vaginal bleeding in subsequent pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; China; Cohort Studies; Curettage; Female; Follow-Up Studies; Humans; Mifepristone; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, First; Pregnancy Trimester, Second; Prospective Studies; Risk; Surveys and Questionnaires; Uterine Hemorrhage; Young Adult | 2011 |
The Th1/Th2/Th17/Treg paradigm induced by stachydrine hydrochloride reduces uterine bleeding in RU486-induced abortion mice.
Topics: Abortion, Induced; Animals; Cytokines; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred BALB C; Mifepristone; Molecular Targeted Therapy; Pregnancy; Progesterone; Proline; Spleen; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Th2 Cells; Transcription Factors; Uterine Hemorrhage | 2013 |
Mifepristone-induced vaginal bleeding is associated with increased immunostaining for cyclooxygenase-2 and decrease in prostaglandin dehydrogenase in luteal phase endometrium.
Topics: Adult; Cyclooxygenase 2; Endometrium; Female; Hormone Antagonists; Humans; Hydroxyprostaglandin Dehydrogenases; Isoenzymes; Kinetics; Luteal Phase; Luteinizing Hormone; Membrane Proteins; Mifepristone; Progesterone; Prostaglandin-Endoperoxide Synthases; Uterine Hemorrhage | 2002 |
[Effect of total glycoside from Clinopodium polycephalum on uterine bleeding quantity in drug abortion model rats].
Topics: Abortion, Induced; Animals; Drugs, Chinese Herbal; Female; Glycosides; Hemostatics; Lamiaceae; Male; Mifepristone; Misoprostol; Phytotherapy; Plants, Medicinal; Pregnancy; Rats; Rats, Wistar; Uterine Hemorrhage | 2002 |
Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Anti-Bacterial Agents; Blood Transfusion; Female; Gestational Age; Humans; Hypersensitivity; Infections; Mifepristone; Misoprostol; Pregnancy; United States; Uterine Hemorrhage; Vacuum Curettage | 2003 |
[Effect of Qinggong Zhixue Granule on low immunity mice].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Drugs, Chinese Herbal; Female; Hemolysin Proteins; Mice; Mifepristone; Plant Preparations; Pregnancy; Random Allocation; Uterine Hemorrhage | 2004 |
Frequently asked questions about medical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Consensus Development Conferences as Topic; Contraception; Counseling; Female; Gestational Age; Health Personnel; Humans; Italy; Mifepristone; Pregnancy; Prostaglandins; Uterine Hemorrhage | 2006 |
[Histopathology appearance of intrauterine residue after medical abortion by mifepristone and prostaglandin analogue].
Topics: Abortion, Induced; Carboprost; Dilatation and Curettage; Drug Synergism; Endometrium; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage | 1994 |
RU486 combined with PGE1 analog in voluntary termination of early pregnancy--a comparison of recent findings with gemeprost or misoprostol.
Topics: Abortion, Induced; Adult; Alprostadil; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Time Factors; Uterine Hemorrhage | 1994 |
Vaginal misoprostol administered at home after mifepristone (RU486) for abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Prospective Studies; Self Administration; United States; Uterine Hemorrhage | 1997 |
Treating colporrhagia after medical abortion with modified shenghua tang.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Animals; Blood Viscosity; Drugs, Chinese Herbal; Female; Humans; Mifepristone; Pregnancy; Rabbits; Uterine Hemorrhage | 1996 |
Unsuccessful treatment of missed abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Missed; Female; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Uterine Hemorrhage | 1998 |
Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Analgesics; Diarrhea; Female; Follow-Up Studies; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage; Vomiting | 1998 |
[Study of histopathology of endometrium following termination of early pregnancy using mifepristone].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Endometrium; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage | 1999 |
Medical management of early fetal demise using a combination of mifepristone and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adult; Curettage; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pregnancy; Uterine Hemorrhage | 2001 |
"Inducing a miscarriage": women-centered perspectives on RU 486/prostaglandin as an early abortion method.
Topics: Abortion, Induced; Ambulatory Care Facilities; England; Female; France; Humans; Internationality; Mifepristone; Multicenter Studies as Topic; Paternalism; Personal Autonomy; Pregnancy; Pregnant Women; Prostaglandins E, Synthetic; Risk Assessment; Time Factors; Uterine Hemorrhage; Vacuum Curettage | 1992 |
The effects of RU-38486 on cervical ripening. Clinical studies.
Topics: Abortion, Induced; Adult; Cervix Uteri; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gestational Age; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Random Allocation; Uterine Hemorrhage | 1990 |
Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. A large-scale French experience.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Dinoprostone; Drug Evaluation; Female; Humans; Mifepristone; Pregnancy; Retrospective Studies; Time Factors; Uterine Hemorrhage | 1990 |
RU 486.
Topics: Abortion, Induced; Animals; Developing Countries; Endometrium; Female; France; Humans; Mifepristone; Models, Molecular; Molecular Structure; Population Control; Pregnancy; Progesterone; Prostaglandins; Rabbits; Receptors, Glucocorticoid; Receptors, Progesterone; Uterine Hemorrhage; Uterus | 1990 |
Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Premedication; Uterine Hemorrhage | 1989 |
[Experiences with the antigestagen mifepristone (RU 486) in the interruption of early pregnancy].
Topics: Abortion, Induced; Adult; Drug Administration Schedule; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Pregnancy, Unwanted; Uterine Hemorrhage | 1989 |
Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
Topics: Adult; Chorionic Gonadotropin; Drug Interactions; Endometrium; Estradiol; Female; Humans; Luteal Phase; Luteinizing Hormone; Mifepristone; Progesterone; Tamoxifen; Uterine Hemorrhage | 1989 |
The safety of early abortion.
Topics: Abortion, Induced; Accident Prevention; Female; Humans; Mifepristone; Pregnancy; Safety; Time Factors; Uterine Hemorrhage | 1989 |
[Early pregnancy interruption using an antiprogesterone steroid: Mifepristone (RU 486)].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Adult; Dose-Response Relationship, Drug; Drug Evaluation; Estrenes; Female; Humans; Mifepristone; Progestins; Uterine Hemorrhage | 1988 |
Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Chorionic Gonadotropin; Drug Evaluation; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone; Uterine Hemorrhage | 1986 |